Latest stories on HURA
TuHURA Biosciences: FDA clears IND for TBS-2025 VISTA-inhibiting antibody
The Fly67 · bullishproduct/pr
TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire56 · neutralgeneral
TuHURA Biosciences draws additional funds from credit facility
TipRanks56 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc. (HURA) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
TuHURA Biosciences Extends Runway as Immuno-Oncology Pipeline Advances
TipRanks63 · neutralproduct/pr
TuHURA Biosciences reports Q2 results
Seeking Alpha50 · neutralearnings
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
PR Newswire50 · neutralearnings
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
PR Newswire56 · neutralgeneral
TuHURA Biosciences Expands Use of Revolving Credit Facility
TipRanks48 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Sets 2026 Virtual Annual Meeting, Proposal Deadlines
TipRanks50 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences reports Q1 results
Seeking Alpha50 · neutralearnings
TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update
PR Newswire50 · neutralearnings
TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
PR Newswire56 · neutralgeneral